May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
TNF–alpha, Macrophages, and Virus Spread in the SCN
Author Affiliations & Notes
  • S.S. Atherton
    Dept of Cellular Biol & Anat, Med Coll of GA, Augusta, GA
  • M.A. Fields
    Dept of Cellular Biol & Anat, Med Coll of GA, Augusta, GA
  • M. Zheng
    Dept of Cellular Biol & Anat, Med Coll of GA, Augusta, GA
  • M. Zhang
    Dept of Cellular Biol & Anat, Med Coll of GA, Augusta, GA
  • Footnotes
    Commercial Relationships  S.S. Atherton, None; M.A. Fields, None; M. Zheng, None; M. Zhang, None.
  • Footnotes
    Support  NIH Grant EY06012, EY06753
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 3539. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S.S. Atherton, M.A. Fields, M. Zheng, M. Zhang; TNF–alpha, Macrophages, and Virus Spread in the SCN . Invest. Ophthalmol. Vis. Sci. 2005;46(13):3539.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To investigate the role of TNF–α and macrophages in the eyes and brain of HSV–1 infected BALB/c mice. Methods: Following uniocular anterior chamber (AC) inoculation of HSV–1, virus spreads to the suprachiasmatic nuclei (SCN) and at day 5 p.i., TNF–α is detected in this area. To determine if macrophages are responsible for production of TNF–α in the SCN and the injected eye, 2×104 of the KOS strain of HSV–1 was injected into the AC of euthymic BALB/c mice. To deplete macrophages, mice in Group 1 (experimental) were injected intravenously with 0.2 ml of dichloromethylene–biphosphate liposomes (Cl2MBP, clodronate) on day –1, 2, and 5. Mice in Group 2 (control) were injected intravenously with 0.2 ml of liposomes containing PBS on day –1, 2, and 5. On day 0, 2×104 PFU HSV–1 (KOS) in a volume of 2 µl was injected in the AC of each mouse. Mice from both groups were sacrificed at day 2, 3, 4, 5, 6, and 7 p.i. and the eyes, brain, and spleen were removed. Fluorescence immunohistochemistry was used to identify and determine the location of HSV–1, macrophages, and TNF–α in the ipsilateral eye, contralateral eye and SCN of HSV–1 infected mice. The titer of virus in the ipsilateral eye, the ipsilateral SCN, and the contralateral SCN was determined by plaque assay. Depletion of macrophages in HSV–1 infected and non–infected mice was determined by flow cytometry. Results: Double staining for macrophages and for TNF–α revealed that macrophages were the primary source of TNF–α in the injected eye and SCN. Virus staining of the contralateral eye revealed increased virus spread in clodronate–treated mice. The titer of virus in the injected eye and ipsilateral SCN was not significantly different between clodronate–treated and control mice. However, the titer of virus in the contralateral SCN was significantly increased in clodronate treated mice compared with controls on day 5 p.i. (9.09 × 103 vs. 3.74 × 102 PFU, p<0.05), and day 7 p.i. (1.52 × 103 vs. 1.41 × 102, p<0.05 ). The titer of virus in the contralateral eye was also significantly increased in clodronate treated mice compared with controls on day 7 p.i. (9.65 × 104 vs. 6.07 × 103, p<0.05). Flow cytometric analysis of splenocytes revealed significantly lower numbers of systemic macrophages in clodronate treated mice compared with controls. Conclusions: TNF–α, produced by macrophages that infiltrate the contralateral SCN following uniocular AC inoculation of HSV–1, plays a role in limiting virus spread from the SCN to the optic nerve and retina of the injected eye which in turn prevents HSV–1 infection of the retina of the injected eye.

Keywords: herpes simplex virus • immunomodulation/immunoregulation • immunohistochemistry 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×